Effect of glutathione combined with cisplatin and oxaliplatin on the proliferation and apoptosis of lung carcinoma cell line

References

• Ashley AC, Sargent DJ, Alberts SR, Grothey A, Campbell ME, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Goldberg RM. 2007. Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX): intergroup trial N9741 in first-line treatment of metastatic colorectal cancer. Cancer 110:670–677.
   PubMed Web of Science ®Google Scholar
• Camano S, Lazaro A, Moreno-Gordaliza E, Torres AM, de Lucas C, Humanes B, Lazaro JA, Gomez-Gomez MM, Bosca L, Tejedor A. 2010. Cilastatin attenuates cisplatin-induced proximal tubular cell damage. J Pharmacol Exp Ther 334:419–429.
   PubMed Web of Science ®Google Scholar
• Deleve LD, Kaplowitz N. 1991. Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther 52:287–305.
   PubMed Web of Science ®Google Scholar
• Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, Crinò L, Benedetti G, Evangelista W, Fanchini L, Cortesi E, Picone V, Vitello S, Chiara S, Granetto C, Porcile G, Fioretto L, Orlandini C, Andreuccetti M, Masi G, Gruppo Oncologico Nord Ovest. 2007. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 25:1670–1676.
   PubMed Web of Science ®Google Scholar
• Go RS, Adjei AA. 1999. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol 17:409–422.
   PubMed Web of Science ®Google Scholar
• Gu Q, Wu W. 2001. Recent advances in pharmacological and clinical studies of glutathione [Chinese]. Pharm Biotechnol 8:47–50.
   Google Scholar
• Guo SZ. 2001. Clinical application of glutathione [Chinese]. J Pharmaceut Pract 19:204–205.
   Google Scholar
• Huang P, Lu H, Chen R-X Luo, ZHX, Xu YA. 2007. Efficacy of reduced glutathione in preventing and treating neurotoxicity of oxaliplatin [Chinese]. Chinese J Clin Oncol Rehab 14:151–153.
   Google Scholar
• Ibrahim A, Hirschfeld S, Cohen MH, Griebel DJ, Williams GA, Pazdur R. 2004. FDA drug approval summaries: oxaliplatin. Oncologist 9:8–12.
   PubMed Web of Science ®Google Scholar
• Isai M, Sakthivel M, Ramesh E, Thomas PA, Geraldine P. 2009. Prevention of selenite-induced cataractogenesis by rutin in wistar rats. Mol Vis 15:2570–2577.
   PubMed Web of Science ®Google Scholar
• Jiang M, Pabla N, Murphy RF, Yang T, Yin XM, Degenhardt K, White E, Dong Z. 2007. Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation. J Biol Chem 282:2636–2645.
   PubMed Web of Science ®Google Scholar
• Jiang N, Lu L, Wang T, Zhang L, Xin W, Fu F. 2010. Reduced glutathione attenuates liver injury induced by methyl parathion in rats. Toxicol Mech Methods 20:69–74.
   PubMed Web of Science ®Google Scholar
• Lee KW, Jeong JY, Lim BJ, Chang YK, Lee SJ, Na KR, Shin YT, Choi DE. 2009. Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Toxicology 257:137–143.
   PubMed Web of Science ®Google Scholar
• Li K, Wang J. 2006. Oxaliplatin-induced peripheral neurotoxicity: clinical treatment and preventive measures [Chinese]. Int J Oncol 33:508–513.
   Google Scholar
• Lu YJ. 2009. Effect of glutathione to control liver damage of paclitaxel and cisplatin chemotherapy for lung cancer [Chinese]. J Clin Pulm Med 14:678.
   Google Scholar
• Mansour HH, Hafez HF, Fahmy NM. 2006. Silymarin modulates cisplatin-induced oxidative stress and hepatotoxicity in rats. J Biochem Mol Biol 39:656–661.
   PubMedGoogle Scholar
• McWhinney SR, Goldberg RM, McLeod HL. 2009. Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther 8:10–16.
   PubMed Web of Science ®Google Scholar
• Nagothu KK, Bhatt R, Kaushal GP, Portilla D. 2005. Fibrate prevents cisplatin-induced proximal tubule cell death. Kidney Int 68:2680–2693.
   PubMed Web of Science ®Google Scholar
• Pabla N, Dong Z. 2008. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73:994–1007.
   PubMed Web of Science ®Google Scholar
• Rajeswaran A, Trojan A, Burnand B, Giannelli M. 2008. Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials. Lung Cancer 59:1–11.
   PubMed Web of Science ®Google Scholar
• Servais H, Ortiz A, Devuyst O, Denamur S, Tulkens PM, Mingeot-Leclercq MP. 2008. Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation. Apoptosis 13:11–32.
   PubMed Web of Science ®Google Scholar
• Shao GL, Wu AG, Jiao DC, Ji SF. 2009. Effect of c-myc antisense oligodeoxynucleotides on proliferation, apoptosis and chemosensitivity of colorectal cancer cell line HT-29 [Chinese]. Shijie Huaren Xiaohua Zazhi 17:459–463.
   Google Scholar
• Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. 1990. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107–1112.
   PubMed Web of Science ®Google Scholar
• Song ZZ, Shang YH, Zang AM, Yang H, Ren LL. 2009. The protective effect of glutathione on neurotoxicity induced by paclitaxel and cisplatin chemotherapy [Chinese]. Shandong Med J 49:98–99.
   Google Scholar
• Sun J, Fu ZM, Fang CQ, Li JH. 2007. Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents. Chin Med J (Engl) 120:400–404.
   PubMedGoogle Scholar
• Voigt W. 2005. Sulforhodamine B assay and chemosensitivity. Methods Mol Med 110:39–48.
   PubMedGoogle Scholar
• Wen SL, Wang GF, Liu SY, Li QZ, Zhong YL, Hao YL. 2009. Protective effect of GSH on nephrotoxicity induced by cisplatin [Chinese]. Occupation and Health 25:341–343.
   Google Scholar
• Wu YJ, Muldoon LL, Neuwelt EA. 2005. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther 312:424–431.
   PubMed Web of Science ®Google Scholar
• Yao X, Panichpisal K, Kurtzman N, Nugent K. 2007. Cisplatin nephrotoxicity: a review. Am J Med Sci 334:115–124.
   PubMed Web of Science ®Google Scholar
• Zhao H. 2007. Glutathione prevent renal damage induced by cisplatin in 104 cases [Chinese]. Shaanxi Med J 36:1213–1216.
   Google Scholar
• Zhao W, Ji M. 2008. Observation on the efficacy of glutathione in preventing neurotoxicity induced by oxaliplatin [Chinese]. Shanghai Med Pharm J 29:517–518.
   Google Scholar